Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease
CVD risk factors tied to cognitive impairment in schizophrenia
4 March 2021Equitably allocating COVID-19 vaccine
4 March 2021Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease
An international team of researchers has identified the CNNM4 protein as a key regulator of magnesium in the liver and potential therapeutic target for non-alcoholic fatty liver disease, according to a study published in the Journal of Hepatology.
